Join Us at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) 2024
We’re excited to invite you to join us at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) 2024, the leading event for professionals dedicated to advancing cancer immunotherapy. This year’s event will be held from November 6th to 10th, 2024, at the George R. Brown Convention Center in Houston, Texas, with virtual attendance options available. SITC 2024 is an essential gathering for immunotherapy researchers, clinicians, and industry experts looking to connect, share insights, and explore the future of cancer treatment.
About SITC 2024
The Society for Immunotherapy of Cancer (SITC) Annual Meeting is a premier event that brings together the brightest minds in cancer immunotherapy. As one of the most anticipated gatherings in the field, SITC 2024 will feature an extensive program of keynote presentations, scientific sessions, and poster presentations that delve into the latest research, breakthrough therapies, and clinical applications in immunotherapy. This conference is ideal for anyone involved in oncology, from research to clinical practice, and offers invaluable opportunities for collaboration and knowledge sharing.
Event Location
Location: George R. Brown Convention Center, Houston, Texas, USA
Virtual attendance options are also available.
Date: November 6th – 10th, 2024
Agenda: Link to Conference Program
Key Speakers and Information
SITC 2024 will host a lineup of distinguished speakers from leading institutions and organizations, covering critical topics in cancer immunotherapy, including:
- Novel Immune Checkpoint Inhibitors
- CAR-T Cell Therapy Advancements
- Emerging Biomarkers for Immunotherapy
- Innovations in Personalized Cancer Vaccines
For a complete list of speakers and the full agenda, visit the conference program.
Who Will Be There?
SITC 2024 attracts a diverse group of attendees, including:
- Oncology Researchers and Clinicians – Leading scientists and practitioners dedicated to advancing cancer immunotherapy.
- Pharmaceutical and Biotech Executives – Professionals from top companies interested in the latest immunotherapy trends and clinical applications.
- Clinical Development Teams – Experts focused on integrating immunotherapy advancements into clinical practice.
- Academic Institutions and Research Centers – Representatives from top universities and research institutes showcasing pioneering work.
This event provides unmatched networking opportunities and a platform to explore the latest in cancer immunotherapy with thought leaders and innovators from across the globe. Don’t miss this chance to be part of the conversation shaping the future of immunotherapy.